Fourpath Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Buy
33,438
+1,945
+6% +$84.6K 0.18% 88
2026
Q2
$1.34M Buy
31,493
+5,531
+21% +$247K 0.18% 98
2026
Q1
$1.25M Buy
25,962
+6,149
+31% +$287K 0.18% 89
2025
Q4
$960K Sell
19,813
-227
-1% -$11.3K 0.13% 105
2025
Q3
$946K Buy
20,040
+44
+0.2% +$2.12K 0.13% 104
2025
Q2
$966K Sell
19,996
-659
-3% -$33.7K 0.15% 97
2025
Q1
$1.15M Buy
20,655
+2,808
+16% +$152K 0.2% 86
2024
Q4
$861K Sell
17,847
-620
-3% -$31.5K 0.16% 97
2024
Q3
$1.06M Buy
18,467
+602
+3% +$32.5K 0.2% 90
2024
Q2
$867K Buy
17,865
+4,366
+32% +$211K 0.64% 31
2024
Q1
$656K Buy
13,499
+4,562
+51% +$223K 0.46% 51
2023
Q4
$444K Sell
8,937
-3,358
-27% -$164K 0.3% 74
2023
Q3
$660K Sell
12,295
-18
-0.1% -$960 0.49% 47
2023
Q2
$664K Buy
12,313
+2,524
+26% +$136K 0.8% 40
2023
Q1
$533K Buy
+9,789
New +$476K 0.37% 68

Other funds holding SNY

Fourpath Capital Management's SNY Position: Q3 2026 in Review

Fourpath Capital Management increased its Sanofi (SNY) stake by 6.2% in Q3 2026, buying an estimated $84.6K and bringing the position to 33,438 shares worth $1.38M. The position accounts for 0.18% of the portfolio, ranked #88.

Fourpath Capital Management first reported a position in SNY in Q1 2023 and has held it in 15 quarters since. 112 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • Fourpath Capital Management held 33,438 shares of Sanofi worth $1.38M as of Q3 2026.
  • Fourpath Capital Management bought 1,945 Sanofi shares in Q3 2026, an estimated $84.6K.
  • Sanofi made up 0.18% of Fourpath Capital Management's portfolio in Q3 2026, its #88 holding.
  • Fourpath Capital Management first reported a position in Sanofi in Q1 2023 and has held it in 15 quarters since.
  • 112 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on Fourpath Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.